nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—breast cancer—Medroxyprogesterone Acetate—uterine cancer	0.211	1	CpDpCtD
Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.171	0.534	CrCtD
Testosterone Propionate—Progesterone—uterine cancer	0.149	0.466	CrCtD
Testosterone Propionate—CYP17A1—Progesterone—uterine cancer	0.0656	0.387	CbGbCtD
Testosterone Propionate—AR—Medroxyprogesterone Acetate—uterine cancer	0.055	0.325	CbGbCtD
Testosterone Propionate—AR—Progesterone—uterine cancer	0.0365	0.215	CbGbCtD
Testosterone Propionate—UGT1A1—Etoposide—uterine cancer	0.0122	0.072	CbGbCtD
Testosterone Propionate—Finasteride—Progesterone—uterine cancer	0.0112	0.047	CrCrCtD
Testosterone Propionate—Stanozolol—Progesterone—uterine cancer	0.00841	0.0354	CrCrCtD
Testosterone Propionate—Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.00834	0.0351	CrCrCtD
Testosterone Propionate—Ethynodiol—Medroxyprogesterone Acetate—uterine cancer	0.00782	0.0329	CrCrCtD
Testosterone Propionate—Nandrolone decanoate—Progesterone—uterine cancer	0.00727	0.0306	CrCrCtD
Testosterone Propionate—Drostanolone—Progesterone—uterine cancer	0.00727	0.0306	CrCrCtD
Testosterone Propionate—Eplerenone—Progesterone—uterine cancer	0.00727	0.0306	CrCrCtD
Testosterone Propionate—Nandrolone phenpropionate—Progesterone—uterine cancer	0.00727	0.0306	CrCrCtD
Testosterone Propionate—Oxandrolone—Progesterone—uterine cancer	0.00682	0.0287	CrCrCtD
Testosterone Propionate—Norgestimate—Progesterone—uterine cancer	0.00682	0.0287	CrCrCtD
Testosterone Propionate—Ethynodiol—Progesterone—uterine cancer	0.00682	0.0287	CrCrCtD
Testosterone Propionate—Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.00662	0.0279	CrCrCtD
Testosterone Propionate—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.00662	0.0279	CrCrCtD
Testosterone Propionate—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.00631	0.0265	CrCrCtD
Testosterone Propionate—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.00631	0.0265	CrCrCtD
Testosterone Propionate—Formestane—Progesterone—uterine cancer	0.00608	0.0256	CrCrCtD
Testosterone Propionate—Dydrogesterone—Progesterone—uterine cancer	0.00578	0.0243	CrCrCtD
Testosterone Propionate—Drospirenone—Progesterone—uterine cancer	0.00578	0.0243	CrCrCtD
Testosterone Propionate—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.00577	0.0243	CrCrCtD
Testosterone Propionate—Potassium Canrenoate—Progesterone—uterine cancer	0.0055	0.0231	CrCrCtD
Testosterone Propionate—Spironolactone—Progesterone—uterine cancer	0.0055	0.0231	CrCrCtD
Testosterone Propionate—Medrysone—Medroxyprogesterone Acetate—uterine cancer	0.00533	0.0224	CrCrCtD
Testosterone Propionate—Megestrol acetate—Progesterone—uterine cancer	0.00503	0.0212	CrCrCtD
Testosterone Propionate—Levonorgestrel—Progesterone—uterine cancer	0.00503	0.0212	CrCrCtD
Testosterone Propionate—Medrysone—Progesterone—uterine cancer	0.00465	0.0195	CrCrCtD
Testosterone Propionate—Danazol—Progesterone—uterine cancer	0.00465	0.0195	CrCrCtD
Testosterone Propionate—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.00464	0.0195	CrCrCtD
Testosterone Propionate—CYP17A1—Steroid Biosynthesis—HSD17B2—uterine cancer	0.00449	0.232	CbGpPWpGaD
Testosterone Propionate—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.00449	0.0189	CrCrCtD
Testosterone Propionate—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.00448	0.0188	CrCrCtD
Testosterone Propionate—Norethindrone—Progesterone—uterine cancer	0.00404	0.017	CrCrCtD
Testosterone Propionate—Hydrocortamate—Progesterone—uterine cancer	0.00404	0.017	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.00401	0.0168	CrCrCtD
Testosterone Propionate—Cortisone acetate—Progesterone—uterine cancer	0.00392	0.0165	CrCrCtD
Testosterone Propionate—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.0039	0.0164	CrCrCtD
Testosterone Propionate—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0039	0.0164	CrCrCtD
Testosterone Propionate—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0038	0.016	CrCrCtD
Testosterone Propionate—Testolactone—Progesterone—uterine cancer	0.0038	0.016	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Progesterone—uterine cancer	0.00349	0.0147	CrCrCtD
Testosterone Propionate—Fludrocortisone—Progesterone—uterine cancer	0.0034	0.0143	CrCrCtD
Testosterone Propionate—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.0142	CrCrCtD
Testosterone Propionate—Methyltestosterone—Progesterone—uterine cancer	0.00332	0.0139	CrCrCtD
Testosterone Propionate—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00318	0.0134	CrCrCtD
Testosterone Propionate—Testosterone—Progesterone—uterine cancer	0.00295	0.0124	CrCrCtD
Testosterone Propionate—Hydrocortisone—Progesterone—uterine cancer	0.00277	0.0117	CrCrCtD
Testosterone Propionate—CYP17A1—Androgen biosynthesis—SRD5A2—uterine cancer	0.00181	0.0936	CbGpPWpGaD
Testosterone Propionate—AR—semen—uterine cancer	0.00152	0.131	CbGeAlD
Testosterone Propionate—AR—oviduct—uterine cancer	0.00111	0.0963	CbGeAlD
Testosterone Propionate—CYP17A1—Glucocorticoid & Mineralcorticoid Metabolism—CYP11A1—uterine cancer	0.00101	0.0522	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.000753	0.0389	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.000544	0.0281	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.000544	0.0281	CbGpPWpGaD
Testosterone Propionate—COMT—myometrium—uterine cancer	0.000487	0.0421	CbGeAlD
Testosterone Propionate—CYP17A1—renal system—uterine cancer	0.000485	0.0419	CbGeAlD
Testosterone Propionate—UGT1A1—renal system—uterine cancer	0.000444	0.0383	CbGeAlD
Testosterone Propionate—CYP17A1—Endogenous sterols—CYP11A1—uterine cancer	0.000435	0.0224	CbGpPWpGaD
Testosterone Propionate—CYP17A1—female reproductive system—uterine cancer	0.000388	0.0336	CbGeAlD
Testosterone Propionate—COMT—uterine cervix—uterine cancer	0.000379	0.0327	CbGeAlD
Testosterone Propionate—COMT—smooth muscle tissue—uterine cancer	0.000368	0.0318	CbGeAlD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—PAWR—uterine cancer	0.000364	0.0188	CbGpPWpGaD
Testosterone Propionate—COMT—decidua—uterine cancer	0.000361	0.0312	CbGeAlD
Testosterone Propionate—AR—myometrium—uterine cancer	0.000356	0.0308	CbGeAlD
Testosterone Propionate—COMT—renal system—uterine cancer	0.000355	0.0306	CbGeAlD
Testosterone Propionate—CYP17A1—female gonad—uterine cancer	0.000353	0.0305	CbGeAlD
Testosterone Propionate—COMT—endometrium—uterine cancer	0.000343	0.0296	CbGeAlD
Testosterone Propionate—COMT—mammalian vulva—uterine cancer	0.000332	0.0286	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.000326	0.0168	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Endogenous sterols—CYP19A1—uterine cancer	0.00032	0.0165	CbGpPWpGaD
Testosterone Propionate—COMT—uterus—uterine cancer	0.000316	0.0273	CbGeAlD
Testosterone Propionate—Finasteride—SRD5A2—uterine cancer	0.000288	0.159	CrCbGaD
Testosterone Propionate—COMT—female reproductive system—uterine cancer	0.000284	0.0245	CbGeAlD
Testosterone Propionate—AR—epithelium—uterine cancer	0.00028	0.0242	CbGeAlD
Testosterone Propionate—AR—uterine cervix—uterine cancer	0.000277	0.024	CbGeAlD
Testosterone Propionate—AR—smooth muscle tissue—uterine cancer	0.00027	0.0233	CbGeAlD
Testosterone Propionate—AR—decidua—uterine cancer	0.000264	0.0228	CbGeAlD
Testosterone Propionate—AR—renal system—uterine cancer	0.00026	0.0224	CbGeAlD
Testosterone Propionate—COMT—female gonad—uterine cancer	0.000258	0.0223	CbGeAlD
Testosterone Propionate—COMT—vagina—uterine cancer	0.000257	0.0222	CbGeAlD
Testosterone Propionate—AR—endometrium—uterine cancer	0.000251	0.0217	CbGeAlD
Testosterone Propionate—AR—mammalian vulva—uterine cancer	0.000243	0.021	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.00024	0.0124	CbGpPWpGaD
Testosterone Propionate—AR—uterus—uterine cancer	0.000231	0.02	CbGeAlD
Testosterone Propionate—CYP17A1—lymph node—uterine cancer	0.000227	0.0196	CbGeAlD
Testosterone Propionate—AR—female reproductive system—uterine cancer	0.000208	0.018	CbGeAlD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000202	0.0104	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000199	0.0103	CbGpPWpGaD
Testosterone Propionate—AR—female gonad—uterine cancer	0.000189	0.0163	CbGeAlD
Testosterone Propionate—AR—Nuclear Receptors—PGR—uterine cancer	0.000188	0.00973	CbGpPWpGaD
Testosterone Propionate—AR—vagina—uterine cancer	0.000188	0.0162	CbGeAlD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000176	0.0091	CbGpPWpGaD
Testosterone Propionate—COMT—lymph node—uterine cancer	0.000166	0.0144	CbGeAlD
Testosterone Propionate—AR—Nuclear Receptors—ESR2—uterine cancer	0.000166	0.00857	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000164	0.00845	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—AKR1B10—uterine cancer	0.000161	0.00831	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000154	0.00796	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—AKR1B1—uterine cancer	0.00015	0.00772	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000149	0.00769	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000148	0.00767	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000147	0.00757	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000143	0.0074	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000137	0.00709	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000131	0.00677	CbGpPWpGaD
Testosterone Propionate—Dydrogesterone—PGR—uterine cancer	0.000124	0.0681	CrCbGaD
Testosterone Propionate—AR—lymph node—uterine cancer	0.000122	0.0105	CbGeAlD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00012	0.00622	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—AKR1C1—uterine cancer	0.00011	0.00567	CbGpPWpGaD
Testosterone Propionate—Alopecia—Progesterone—uterine cancer	0.000109	0.00371	CcSEcCtD
Testosterone Propionate—Mental disorder—Progesterone—uterine cancer	0.000108	0.00368	CcSEcCtD
Testosterone Propionate—Malnutrition—Progesterone—uterine cancer	0.000108	0.00365	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000105	0.00543	CbGpPWpGaD
Testosterone Propionate—Seborrhoeic dermatitis—Epirubicin—uterine cancer	0.000104	0.00352	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—ABCC9—uterine cancer	0.000103	0.00532	CbGpPWpGaD
Testosterone Propionate—Ethynodiol—PGR—uterine cancer	0.000102	0.0561	CrCbGaD
Testosterone Propionate—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000102	0.00345	CcSEcCtD
Testosterone Propionate—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000101	0.00344	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000101	0.00343	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—ESR1—uterine cancer	0.000101	0.0052	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Progesterone—uterine cancer	9.98e-05	0.00339	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—uterine cancer	9.91e-05	0.00512	CbGpPWpGaD
Testosterone Propionate—Alopecia—Medroxyprogesterone Acetate—uterine cancer	9.9e-05	0.00336	CcSEcCtD
Testosterone Propionate—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	9.81e-05	0.00333	CcSEcCtD
Testosterone Propionate—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	9.75e-05	0.00331	CcSEcCtD
Testosterone Propionate—Malaise—Progesterone—uterine cancer	9.7e-05	0.0033	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—AKR1B10—uterine cancer	9.64e-05	0.00498	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—GPX3—uterine cancer	9.64e-05	0.00498	CbGpPWpGaD
Testosterone Propionate—Seborrhoeic dermatitis—Doxorubicin—uterine cancer	9.58e-05	0.00325	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Etoposide—uterine cancer	9.44e-05	0.00321	CcSEcCtD
Testosterone Propionate—Hypertension—Progesterone—uterine cancer	9.29e-05	0.00315	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GPX3—uterine cancer	9.23e-05	0.00477	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Progesterone—uterine cancer	9.16e-05	0.00311	CcSEcCtD
Testosterone Propionate—Myalgia—Progesterone—uterine cancer	9.16e-05	0.00311	CcSEcCtD
Testosterone Propionate—Anxiety—Progesterone—uterine cancer	9.13e-05	0.0031	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	9.1e-05	0.00309	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP11A1—uterine cancer	9.07e-05	0.00469	CbGpPWpGaD
Testosterone Propionate—Discomfort—Progesterone—uterine cancer	9.05e-05	0.00307	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	9.05e-05	0.00307	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MSH6—uterine cancer	9.02e-05	0.00466	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—AKR1B1—uterine cancer	8.96e-05	0.00463	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP11A1—uterine cancer	8.95e-05	0.00462	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—ESR1—uterine cancer	8.95e-05	0.00462	CbGpPWpGaD
Testosterone Propionate—Confusional state—Progesterone—uterine cancer	8.85e-05	0.00301	CcSEcCtD
Testosterone Propionate—Rash pustular—Epirubicin—uterine cancer	8.85e-05	0.00301	CcSEcCtD
Testosterone Propionate—Malaise—Medroxyprogesterone Acetate—uterine cancer	8.79e-05	0.00299	CcSEcCtD
Testosterone Propionate—Oedema—Progesterone—uterine cancer	8.78e-05	0.00298	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Progesterone—uterine cancer	8.78e-05	0.00298	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP11A1—uterine cancer	8.69e-05	0.00449	CbGpPWpGaD
Testosterone Propionate—Norgestimate—PGR—uterine cancer	8.67e-05	0.0477	CrCbGaD
Testosterone Propionate—Nervous system disorder—Progesterone—uterine cancer	8.61e-05	0.00292	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP11A1—uterine cancer	8.57e-05	0.00443	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Progesterone—uterine cancer	8.53e-05	0.0029	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—AKR1C3—uterine cancer	8.45e-05	0.00436	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	8.3e-05	0.00282	CcSEcCtD
Testosterone Propionate—Myalgia—Medroxyprogesterone Acetate—uterine cancer	8.3e-05	0.00282	CcSEcCtD
Testosterone Propionate—Anxiety—Medroxyprogesterone Acetate—uterine cancer	8.27e-05	0.00281	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	8.24e-05	0.0028	CcSEcCtD
Testosterone Propionate—Discomfort—Medroxyprogesterone Acetate—uterine cancer	8.2e-05	0.00279	CcSEcCtD
Testosterone Propionate—Rash pustular—Doxorubicin—uterine cancer	8.19e-05	0.00278	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—AKR1C3—uterine cancer	8.09e-05	0.00418	CbGpPWpGaD
Testosterone Propionate—Breast pain—Epirubicin—uterine cancer	8.09e-05	0.00275	CcSEcCtD
Testosterone Propionate—Jaundice cholestatic—Epirubicin—uterine cancer	8.03e-05	0.00273	CcSEcCtD
Testosterone Propionate—Confusional state—Medroxyprogesterone Acetate—uterine cancer	8.02e-05	0.00272	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Progesterone—uterine cancer	8e-05	0.00272	CcSEcCtD
Testosterone Propionate—Oedema—Medroxyprogesterone Acetate—uterine cancer	7.96e-05	0.0027	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	7.96e-05	0.0027	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	7.95e-05	0.00411	CbGpPWpGaD
Testosterone Propionate—Insomnia—Progesterone—uterine cancer	7.94e-05	0.0027	CcSEcCtD
Testosterone Propionate—Danazol—CCL2—uterine cancer	7.94e-05	0.0437	CrCbGaD
Testosterone Propionate—Paraesthesia—Progesterone—uterine cancer	7.88e-05	0.00268	CcSEcCtD
Testosterone Propionate—Dyspnoea—Progesterone—uterine cancer	7.83e-05	0.00266	CcSEcCtD
Testosterone Propionate—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	7.81e-05	0.043	CrCbGaD
Testosterone Propionate—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	7.8e-05	0.00265	CcSEcCtD
Testosterone Propionate—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	7.73e-05	0.00262	CcSEcCtD
Testosterone Propionate—Alopecia—Dactinomycin—uterine cancer	7.72e-05	0.00262	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.71e-05	0.00398	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	7.67e-05	0.00396	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Progesterone—uterine cancer	7.58e-05	0.00257	CcSEcCtD
Testosterone Propionate—Fatigue—Progesterone—uterine cancer	7.57e-05	0.00257	CcSEcCtD
Testosterone Propionate—Pain—Progesterone—uterine cancer	7.51e-05	0.00255	CcSEcCtD
Testosterone Propionate—Breast pain—Doxorubicin—uterine cancer	7.48e-05	0.00254	CcSEcCtD
Testosterone Propionate—Megestrol acetate—PGR—uterine cancer	7.45e-05	0.041	CrCbGaD
Testosterone Propionate—Jaundice cholestatic—Doxorubicin—uterine cancer	7.43e-05	0.00252	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	7.37e-05	0.00381	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MSH2—uterine cancer	7.31e-05	0.00378	CbGpPWpGaD
Testosterone Propionate—Inflammation—Epirubicin—uterine cancer	7.28e-05	0.00247	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	7.25e-05	0.00246	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Progesterone—uterine cancer	7.24e-05	0.00246	CcSEcCtD
Testosterone Propionate—Nandrolone phenpropionate—CYP19A1—uterine cancer	7.23e-05	0.0397	CrCbGaD
Testosterone Propionate—Insomnia—Medroxyprogesterone Acetate—uterine cancer	7.2e-05	0.00244	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Progesterone—uterine cancer	7.18e-05	0.00244	CcSEcCtD
Testosterone Propionate—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	7.14e-05	0.00243	CcSEcCtD
Testosterone Propionate—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	7.09e-05	0.00241	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Dactinomycin—uterine cancer	7.06e-05	0.0024	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—NFE2L2—uterine cancer	7e-05	0.00361	CbGpPWpGaD
Testosterone Propionate—Urticaria—Progesterone—uterine cancer	6.98e-05	0.00237	CcSEcCtD
Testosterone Propionate—Abdominal pain—Progesterone—uterine cancer	6.94e-05	0.00236	CcSEcCtD
Testosterone Propionate—Testolactone—CYP19A1—uterine cancer	6.89e-05	0.0379	CrCbGaD
Testosterone Propionate—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	6.87e-05	0.00233	CcSEcCtD
Testosterone Propionate—Fatigue—Medroxyprogesterone Acetate—uterine cancer	6.86e-05	0.00233	CcSEcCtD
Testosterone Propionate—Malaise—Dactinomycin—uterine cancer	6.86e-05	0.00233	CcSEcCtD
Testosterone Propionate—Inflammation—Doxorubicin—uterine cancer	6.73e-05	0.00229	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	6.73e-05	0.00348	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP19A1—uterine cancer	6.68e-05	0.00345	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GPX3—uterine cancer	6.68e-05	0.00345	CbGpPWpGaD
Testosterone Propionate—Hepatobiliary disease—Etoposide—uterine cancer	6.66e-05	0.00226	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP19A1—uterine cancer	6.58e-05	0.0034	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—AKR1C1—uterine cancer	6.58e-05	0.0034	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	6.56e-05	0.00223	CcSEcCtD
Testosterone Propionate—Drospirenone—PGR—uterine cancer	6.51e-05	0.0358	CrCbGaD
Testosterone Propionate—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	6.51e-05	0.00221	CcSEcCtD
Testosterone Propionate—Myalgia—Dactinomycin—uterine cancer	6.47e-05	0.0022	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Progesterone—uterine cancer	6.47e-05	0.0022	CcSEcCtD
Testosterone Propionate—Ethynodiol—ESR1—uterine cancer	6.44e-05	0.0354	CrCbGaD
Testosterone Propionate—Discomfort—Dactinomycin—uterine cancer	6.4e-05	0.00217	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP19A1—uterine cancer	6.39e-05	0.0033	CbGpPWpGaD
Testosterone Propionate—Neoplasm—Epirubicin—uterine cancer	6.38e-05	0.00217	CcSEcCtD
Testosterone Propionate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	6.32e-05	0.00215	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP19A1—uterine cancer	6.31e-05	0.00326	CbGpPWpGaD
Testosterone Propionate—Asthenia—Progesterone—uterine cancer	6.3e-05	0.00214	CcSEcCtD
Testosterone Propionate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	6.29e-05	0.00214	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Etoposide—uterine cancer	6.24e-05	0.00212	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—SMAD3—uterine cancer	6.24e-05	0.00322	CbGpPWpGaD
Testosterone Propionate—Pruritus—Progesterone—uterine cancer	6.21e-05	0.00211	CcSEcCtD
Testosterone Propionate—Oedema—Dactinomycin—uterine cancer	6.21e-05	0.00211	CcSEcCtD
Testosterone Propionate—Urethral disorder—Etoposide—uterine cancer	6.2e-05	0.0021	CcSEcCtD
Testosterone Propionate—Drostanolone—CYP19A1—uterine cancer	6.14e-05	0.0338	CrCbGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—CDKN1B—uterine cancer	6.08e-05	0.00314	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Progesterone—uterine cancer	6.01e-05	0.00204	CcSEcCtD
Testosterone Propionate—Neoplasm—Doxorubicin—uterine cancer	5.9e-05	0.00201	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	5.86e-05	0.00199	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—YWHAE—uterine cancer	5.81e-05	0.003	CbGpPWpGaD
Testosterone Propionate—Dizziness—Progesterone—uterine cancer	5.81e-05	0.00197	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GPX3—uterine cancer	5.77e-05	0.00298	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CDKN1B—uterine cancer	5.77e-05	0.00298	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Etoposide—uterine cancer	5.74e-05	0.00195	CcSEcCtD
Testosterone Propionate—Immune system disorder—Etoposide—uterine cancer	5.71e-05	0.00194	CcSEcCtD
Testosterone Propionate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	5.71e-05	0.00194	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Etoposide—uterine cancer	5.7e-05	0.00194	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Dactinomycin—uterine cancer	5.65e-05	0.00192	CcSEcCtD
Testosterone Propionate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	5.63e-05	0.00191	CcSEcCtD
Testosterone Propionate—Alopecia—Etoposide—uterine cancer	5.59e-05	0.0019	CcSEcCtD
Testosterone Propionate—Vomiting—Progesterone—uterine cancer	5.58e-05	0.0019	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.58e-05	0.00288	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.58e-05	0.00288	CbGpPWpGaD
Testosterone Propionate—Rash—Progesterone—uterine cancer	5.54e-05	0.00188	CcSEcCtD
Testosterone Propionate—Dermatitis—Progesterone—uterine cancer	5.53e-05	0.00188	CcSEcCtD
Testosterone Propionate—Headache—Progesterone—uterine cancer	5.5e-05	0.00187	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	5.49e-05	0.00284	CbGpPWpGaD
Testosterone Propionate—Norgestimate—ESR1—uterine cancer	5.48e-05	0.0301	CrCbGaD
Testosterone Propionate—Nandrolone decanoate—CYP19A1—uterine cancer	5.48e-05	0.0301	CrCbGaD
Testosterone Propionate—Increased appetite—Epirubicin—uterine cancer	5.45e-05	0.00185	CcSEcCtD
Testosterone Propionate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	5.44e-05	0.00185	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP11A1—uterine cancer	5.44e-05	0.00281	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP11A1—uterine cancer	5.36e-05	0.00277	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—ESR2—uterine cancer	5.36e-05	0.00277	CbGpPWpGaD
Testosterone Propionate—Dermatitis bullous—Epirubicin—uterine cancer	5.36e-05	0.00182	CcSEcCtD
Testosterone Propionate—Fatigue—Dactinomycin—uterine cancer	5.35e-05	0.00182	CcSEcCtD
Testosterone Propionate—AR—FOXA1 transcription factor network—EP300—uterine cancer	5.34e-05	0.00276	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—PGR—uterine cancer	5.31e-05	0.0292	CrCbGaD
Testosterone Propionate—Pain—Dactinomycin—uterine cancer	5.31e-05	0.0018	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Epirubicin—uterine cancer	5.29e-05	0.0018	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CDKN2A—uterine cancer	5.29e-05	0.00273	CbGpPWpGaD
Testosterone Propionate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	5.26e-05	0.00179	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	5.23e-05	0.0027	CbGpPWpGaD
Testosterone Propionate—Nausea—Progesterone—uterine cancer	5.22e-05	0.00177	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	5.22e-05	0.00269	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	5.12e-05	0.00174	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Dactinomycin—uterine cancer	5.11e-05	0.00174	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Etoposide—uterine cancer	5.11e-05	0.00173	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Dactinomycin—uterine cancer	5.08e-05	0.00172	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—EP300—uterine cancer	5.07e-05	0.00262	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—AKR1C3—uterine cancer	5.06e-05	0.00261	CbGpPWpGaD
Testosterone Propionate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	5.06e-05	0.00172	CcSEcCtD
Testosterone Propionate—Increased appetite—Doxorubicin—uterine cancer	5.05e-05	0.00171	CcSEcCtD
Testosterone Propionate—Rash—Medroxyprogesterone Acetate—uterine cancer	5.02e-05	0.0017	CcSEcCtD
Testosterone Propionate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	5.01e-05	0.0017	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	5e-05	0.00258	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—STK11—uterine cancer	5e-05	0.00258	CbGpPWpGaD
Testosterone Propionate—Headache—Medroxyprogesterone Acetate—uterine cancer	4.98e-05	0.00169	CcSEcCtD
Testosterone Propionate—Malaise—Etoposide—uterine cancer	4.96e-05	0.00169	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Doxorubicin—uterine cancer	4.96e-05	0.00168	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	4.92e-05	0.00254	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Dactinomycin—uterine cancer	4.91e-05	0.00167	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Doxorubicin—uterine cancer	4.9e-05	0.00166	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—uterine cancer	4.84e-05	0.0025	CbGpPWpGaD
Testosterone Propionate—Danazol—PGR—uterine cancer	4.84e-05	0.0266	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	4.83e-05	0.00249	CbGpPWpGaD
Testosterone Propionate—Hypertension—Etoposide—uterine cancer	4.75e-05	0.00161	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	4.74e-05	0.00161	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Epirubicin—uterine cancer	4.73e-05	0.00161	CcSEcCtD
Testosterone Propionate—Nausea—Medroxyprogesterone Acetate—uterine cancer	4.73e-05	0.00161	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	4.65e-05	0.00158	CcSEcCtD
Testosterone Propionate—Spironolactone—PGR—uterine cancer	4.63e-05	0.0255	CrCbGaD
Testosterone Propionate—Discomfort—Etoposide—uterine cancer	4.63e-05	0.00157	CcSEcCtD
Testosterone Propionate—Breast disorder—Epirubicin—uterine cancer	4.63e-05	0.00157	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—EP300—uterine cancer	4.6e-05	0.00238	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	4.58e-05	0.00237	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Dactinomycin—uterine cancer	4.57e-05	0.00155	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	4.56e-05	0.00235	CbGpPWpGaD
Testosterone Propionate—Confusional state—Etoposide—uterine cancer	4.53e-05	0.00154	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Etoposide—uterine cancer	4.49e-05	0.00153	CcSEcCtD
Testosterone Propionate—Asthenia—Dactinomycin—uterine cancer	4.45e-05	0.00151	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CTNNB1—uterine cancer	4.42e-05	0.00229	CbGpPWpGaD
Testosterone Propionate—Liver function test abnormal—Doxorubicin—uterine cancer	4.38e-05	0.00149	CcSEcCtD
Testosterone Propionate—Skin disorder—Etoposide—uterine cancer	4.36e-05	0.00148	CcSEcCtD
Testosterone Propionate—Medroxyprogesterone Acetate—PGR—uterine cancer	4.34e-05	0.0239	CrCbGaD
Testosterone Propionate—Norethindrone—PGR—uterine cancer	4.3e-05	0.0237	CrCbGaD
Testosterone Propionate—Breast disorder—Doxorubicin—uterine cancer	4.28e-05	0.00145	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—uterine cancer	4.27e-05	0.00221	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	4.26e-05	0.0022	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Dactinomycin—uterine cancer	4.25e-05	0.00144	CcSEcCtD
Testosterone Propionate—Dysuria—Epirubicin—uterine cancer	4.14e-05	0.00141	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.14e-05	0.00214	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.09e-05	0.00211	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Etoposide—uterine cancer	4.03e-05	0.00137	CcSEcCtD
Testosterone Propionate—Weight increased—Epirubicin—uterine cancer	4.03e-05	0.00137	CcSEcCtD
Testosterone Propionate—Dyspnoea—Etoposide—uterine cancer	4e-05	0.00136	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP19A1—uterine cancer	4e-05	0.00207	CbGpPWpGaD
Testosterone Propionate—Vomiting—Dactinomycin—uterine cancer	3.95e-05	0.00134	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP19A1—uterine cancer	3.94e-05	0.00204	CbGpPWpGaD
Testosterone Propionate—Rash—Dactinomycin—uterine cancer	3.91e-05	0.00133	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Etoposide—uterine cancer	3.88e-05	0.00132	CcSEcCtD
Testosterone Propionate—Fatigue—Etoposide—uterine cancer	3.87e-05	0.00132	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	3.86e-05	0.00199	CbGpPWpGaD
Testosterone Propionate—Pain—Etoposide—uterine cancer	3.84e-05	0.0013	CcSEcCtD
Testosterone Propionate—Dysuria—Doxorubicin—uterine cancer	3.83e-05	0.0013	CcSEcCtD
Testosterone Propionate—Haematuria—Epirubicin—uterine cancer	3.76e-05	0.00128	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Epirubicin—uterine cancer	3.73e-05	0.00127	CcSEcCtD
Testosterone Propionate—Weight increased—Doxorubicin—uterine cancer	3.73e-05	0.00127	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.71e-05	0.00192	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Etoposide—uterine cancer	3.7e-05	0.00126	CcSEcCtD
Testosterone Propionate—Nausea—Dactinomycin—uterine cancer	3.69e-05	0.00125	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Etoposide—uterine cancer	3.67e-05	0.00125	CcSEcCtD
Testosterone Propionate—Levonorgestrel—CYP19A1—uterine cancer	3.64e-05	0.02	CrCbGaD
Testosterone Propionate—COMT—Metabolism—SRD5A2—uterine cancer	3.59e-05	0.00185	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NDUFB11—uterine cancer	3.59e-05	0.00185	CbGpPWpGaD
Testosterone Propionate—Urticaria—Etoposide—uterine cancer	3.57e-05	0.00121	CcSEcCtD
Testosterone Propionate—Haemoglobin—Epirubicin—uterine cancer	3.56e-05	0.00121	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	3.56e-05	0.00184	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Etoposide—uterine cancer	3.55e-05	0.00121	CcSEcCtD
Testosterone Propionate—Haemorrhage—Epirubicin—uterine cancer	3.54e-05	0.0012	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Epirubicin—uterine cancer	3.5e-05	0.00119	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—PHF1—uterine cancer	3.49e-05	0.0018	CbGpPWpGaD
Testosterone Propionate—Haematuria—Doxorubicin—uterine cancer	3.48e-05	0.00118	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Epirubicin—uterine cancer	3.48e-05	0.00118	CcSEcCtD
Testosterone Propionate—Urethral disorder—Epirubicin—uterine cancer	3.47e-05	0.00118	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—uterine cancer	3.45e-05	0.00117	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—SRD5A2—uterine cancer	3.44e-05	0.00177	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NDUFB11—uterine cancer	3.44e-05	0.00177	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—ESR1—uterine cancer	3.35e-05	0.0184	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.34e-05	0.00172	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.34e-05	0.00172	CbGpPWpGaD
Testosterone Propionate—Danazol—CYP19A1—uterine cancer	3.32e-05	0.0182	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	3.31e-05	0.00171	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Etoposide—uterine cancer	3.31e-05	0.00112	CcSEcCtD
Testosterone Propionate—Haemoglobin—Doxorubicin—uterine cancer	3.3e-05	0.00112	CcSEcCtD
Testosterone Propionate—Haemorrhage—Doxorubicin—uterine cancer	3.28e-05	0.00111	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	3.28e-05	0.00169	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	3.27e-05	0.00169	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—uterine cancer	3.24e-05	0.0011	CcSEcCtD
Testosterone Propionate—Asthenia—Etoposide—uterine cancer	3.22e-05	0.00109	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—uterine cancer	3.22e-05	0.00109	CcSEcCtD
Testosterone Propionate—Angiopathy—Epirubicin—uterine cancer	3.22e-05	0.00109	CcSEcCtD
Testosterone Propionate—Urethral disorder—Doxorubicin—uterine cancer	3.21e-05	0.00109	CcSEcCtD
Testosterone Propionate—Immune system disorder—Epirubicin—uterine cancer	3.2e-05	0.00109	CcSEcCtD
Testosterone Propionate—Fluoxymesterone—ESR1—uterine cancer	3.19e-05	0.0176	CrCbGaD
Testosterone Propionate—Mediastinal disorder—Epirubicin—uterine cancer	3.19e-05	0.00108	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	3.19e-05	0.00165	CbGpPWpGaD
Testosterone Propionate—Pruritus—Etoposide—uterine cancer	3.18e-05	0.00108	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.15e-05	0.00163	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP11A1—uterine cancer	3.14e-05	0.0173	CrCbGaD
Testosterone Propionate—Alopecia—Epirubicin—uterine cancer	3.13e-05	0.00106	CcSEcCtD
Testosterone Propionate—Mental disorder—Epirubicin—uterine cancer	3.11e-05	0.00105	CcSEcCtD
Testosterone Propionate—Malnutrition—Epirubicin—uterine cancer	3.09e-05	0.00105	CcSEcCtD
Testosterone Propionate—Diarrhoea—Etoposide—uterine cancer	3.07e-05	0.00104	CcSEcCtD
Testosterone Propionate—Danazol—ESR1—uterine cancer	3.05e-05	0.0168	CrCbGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EP300—uterine cancer	3.04e-05	0.00157	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Doxorubicin—uterine cancer	2.98e-05	0.00101	CcSEcCtD
Testosterone Propionate—Dizziness—Etoposide—uterine cancer	2.97e-05	0.00101	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—CHD4—uterine cancer	2.97e-05	0.00153	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Doxorubicin—uterine cancer	2.96e-05	0.00101	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—uterine cancer	2.96e-05	0.001	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.9e-05	0.0015	CbGpPWpGaD
Testosterone Propionate—Alopecia—Doxorubicin—uterine cancer	2.9e-05	0.000984	CcSEcCtD
Testosterone Propionate—Mental disorder—Doxorubicin—uterine cancer	2.87e-05	0.000976	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Epirubicin—uterine cancer	2.86e-05	0.000972	CcSEcCtD
Testosterone Propionate—Vomiting—Etoposide—uterine cancer	2.86e-05	0.00097	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—uterine cancer	2.85e-05	0.00097	CcSEcCtD
Testosterone Propionate—Rash—Etoposide—uterine cancer	2.83e-05	0.000962	CcSEcCtD
Testosterone Propionate—Dermatitis—Etoposide—uterine cancer	2.83e-05	0.000961	CcSEcCtD
Testosterone Propionate—Headache—Etoposide—uterine cancer	2.81e-05	0.000956	CcSEcCtD
Testosterone Propionate—Methyltestosterone—CYP19A1—uterine cancer	2.8e-05	0.0154	CrCbGaD
Testosterone Propionate—Malaise—Epirubicin—uterine cancer	2.78e-05	0.000945	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.77e-05	0.00143	CbGpPWpGaD
Testosterone Propionate—Medroxyprogesterone Acetate—ESR1—uterine cancer	2.74e-05	0.0151	CrCbGaD
Testosterone Propionate—Nausea—Etoposide—uterine cancer	2.67e-05	0.000906	CcSEcCtD
Testosterone Propionate—Hypertension—Epirubicin—uterine cancer	2.66e-05	0.000905	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—uterine cancer	2.65e-05	0.0009	CcSEcCtD
Testosterone Propionate—Myalgia—Epirubicin—uterine cancer	2.63e-05	0.000892	CcSEcCtD
Testosterone Propionate—Arthralgia—Epirubicin—uterine cancer	2.63e-05	0.000892	CcSEcCtD
Testosterone Propionate—Anxiety—Epirubicin—uterine cancer	2.62e-05	0.000889	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	2.61e-05	0.000886	CcSEcCtD
Testosterone Propionate—Discomfort—Epirubicin—uterine cancer	2.6e-05	0.000881	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—AKR1B1—uterine cancer	2.59e-05	0.00134	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—STAR—uterine cancer	2.59e-05	0.00134	CbGpPWpGaD
Testosterone Propionate—Malaise—Doxorubicin—uterine cancer	2.57e-05	0.000874	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—PGR—uterine cancer	2.57e-05	0.00133	CbGpPWpGaD
Testosterone Propionate—Confusional state—Epirubicin—uterine cancer	2.54e-05	0.000862	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Epirubicin—uterine cancer	2.52e-05	0.000855	CcSEcCtD
Testosterone Propionate—Oedema—Epirubicin—uterine cancer	2.52e-05	0.000855	CcSEcCtD
Testosterone Propionate—Progesterone—PGR—uterine cancer	2.51e-05	0.0138	CrCbGaD
Testosterone Propionate—AR—Gene Expression—SUZ12—uterine cancer	2.49e-05	0.00128	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	2.49e-05	0.00128	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKR1B1—uterine cancer	2.48e-05	0.00128	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—STAR—uterine cancer	2.48e-05	0.00128	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Epirubicin—uterine cancer	2.47e-05	0.000839	CcSEcCtD
Testosterone Propionate—Hypertension—Doxorubicin—uterine cancer	2.46e-05	0.000837	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.46e-05	0.00127	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Epirubicin—uterine cancer	2.45e-05	0.000831	CcSEcCtD
Testosterone Propionate—Myalgia—Doxorubicin—uterine cancer	2.43e-05	0.000825	CcSEcCtD
Testosterone Propionate—Arthralgia—Doxorubicin—uterine cancer	2.43e-05	0.000825	CcSEcCtD
Testosterone Propionate—Anxiety—Doxorubicin—uterine cancer	2.42e-05	0.000823	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	2.41e-05	0.00082	CcSEcCtD
Testosterone Propionate—Discomfort—Doxorubicin—uterine cancer	2.4e-05	0.000816	CcSEcCtD
Testosterone Propionate—Confusional state—Doxorubicin—uterine cancer	2.35e-05	0.000798	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—uterine cancer	2.33e-05	0.000791	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—uterine cancer	2.33e-05	0.000791	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Epirubicin—uterine cancer	2.29e-05	0.000779	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Doxorubicin—uterine cancer	2.28e-05	0.000776	CcSEcCtD
Testosterone Propionate—Insomnia—Epirubicin—uterine cancer	2.28e-05	0.000773	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR2—uterine cancer	2.26e-05	0.00117	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Doxorubicin—uterine cancer	2.26e-05	0.000769	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	2.26e-05	0.00117	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Epirubicin—uterine cancer	2.26e-05	0.000768	CcSEcCtD
Testosterone Propionate—Dyspnoea—Epirubicin—uterine cancer	2.24e-05	0.000762	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Epirubicin—uterine cancer	2.17e-05	0.000738	CcSEcCtD
Testosterone Propionate—Fatigue—Epirubicin—uterine cancer	2.17e-05	0.000737	CcSEcCtD
Testosterone Propionate—Pain—Epirubicin—uterine cancer	2.15e-05	0.000731	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—SRD5A2—uterine cancer	2.15e-05	0.00111	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NDUFB11—uterine cancer	2.15e-05	0.00111	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.14e-05	0.00111	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	2.12e-05	0.000721	CcSEcCtD
Testosterone Propionate—Insomnia—Doxorubicin—uterine cancer	2.11e-05	0.000716	CcSEcCtD
Testosterone Propionate—Paraesthesia—Doxorubicin—uterine cancer	2.09e-05	0.000711	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.09e-05	0.00108	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.09e-05	0.00108	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Doxorubicin—uterine cancer	2.08e-05	0.000705	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Epirubicin—uterine cancer	2.07e-05	0.000705	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Epirubicin—uterine cancer	2.06e-05	0.000699	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—POLD1—uterine cancer	2.04e-05	0.00105	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.03e-05	0.00105	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.01e-05	0.000683	CcSEcCtD
Testosterone Propionate—Fatigue—Doxorubicin—uterine cancer	2.01e-05	0.000682	CcSEcCtD
Testosterone Propionate—Urticaria—Epirubicin—uterine cancer	2e-05	0.000679	CcSEcCtD
Testosterone Propionate—Pain—Doxorubicin—uterine cancer	1.99e-05	0.000677	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.99e-05	0.00103	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Epirubicin—uterine cancer	1.99e-05	0.000676	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.98e-05	0.00102	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—POLD1—uterine cancer	1.95e-05	0.00101	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	1.94e-05	0.001	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Doxorubicin—uterine cancer	1.92e-05	0.000652	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—uterine cancer	1.91e-05	0.000647	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—AKR1C1—uterine cancer	1.9e-05	0.000983	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.89e-05	0.000974	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.88e-05	0.000971	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Epirubicin—uterine cancer	1.86e-05	0.00063	CcSEcCtD
Testosterone Propionate—Urticaria—Doxorubicin—uterine cancer	1.85e-05	0.000629	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.84e-05	0.000952	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Doxorubicin—uterine cancer	1.84e-05	0.000626	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.84e-05	0.000949	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	1.84e-05	0.000949	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKR1C1—uterine cancer	1.82e-05	0.000941	CbGpPWpGaD
Testosterone Propionate—Asthenia—Epirubicin—uterine cancer	1.81e-05	0.000614	CcSEcCtD
Testosterone Propionate—Pruritus—Epirubicin—uterine cancer	1.78e-05	0.000605	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.78e-05	0.000917	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.73e-05	0.000894	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Epirubicin—uterine cancer	1.72e-05	0.000585	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Doxorubicin—uterine cancer	1.72e-05	0.000583	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—RRM2—uterine cancer	1.7e-05	0.000876	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—SMAD3—uterine cancer	1.68e-05	0.000869	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—uterine cancer	1.67e-05	0.000568	CcSEcCtD
Testosterone Propionate—Dizziness—Epirubicin—uterine cancer	1.67e-05	0.000566	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.65e-05	0.000852	CbGpPWpGaD
Testosterone Propionate—Pruritus—Doxorubicin—uterine cancer	1.65e-05	0.00056	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—DCN—uterine cancer	1.65e-05	0.000851	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP19A1—uterine cancer	1.63e-05	0.00894	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—RRM2—uterine cancer	1.62e-05	0.000839	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—uterine cancer	1.61e-05	0.000834	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.6e-05	0.000828	CbGpPWpGaD
Testosterone Propionate—Vomiting—Epirubicin—uterine cancer	1.6e-05	0.000544	CcSEcCtD
Testosterone Propionate—Diarrhoea—Doxorubicin—uterine cancer	1.59e-05	0.000541	CcSEcCtD
Testosterone Propionate—Rash—Epirubicin—uterine cancer	1.59e-05	0.000539	CcSEcCtD
Testosterone Propionate—Dermatitis—Epirubicin—uterine cancer	1.59e-05	0.000539	CcSEcCtD
Testosterone Propionate—Progesterone—ESR1—uterine cancer	1.58e-05	0.00871	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—DCN—uterine cancer	1.58e-05	0.000815	CbGpPWpGaD
Testosterone Propionate—Headache—Epirubicin—uterine cancer	1.58e-05	0.000536	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.56e-05	0.000807	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKR1B1—uterine cancer	1.55e-05	0.000802	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—STAR—uterine cancer	1.55e-05	0.000802	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP11A1—uterine cancer	1.55e-05	0.000801	CbGpPWpGaD
Testosterone Propionate—Dizziness—Doxorubicin—uterine cancer	1.54e-05	0.000523	CcSEcCtD
Testosterone Propionate—Nausea—Epirubicin—uterine cancer	1.5e-05	0.000508	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CYP11A1—uterine cancer	1.49e-05	0.000767	CbGpPWpGaD
Testosterone Propionate—Vomiting—Doxorubicin—uterine cancer	1.48e-05	0.000503	CcSEcCtD
Testosterone Propionate—Rash—Doxorubicin—uterine cancer	1.47e-05	0.000499	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—uterine cancer	1.47e-05	0.000498	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—AKR1C3—uterine cancer	1.47e-05	0.000757	CbGpPWpGaD
Testosterone Propionate—Headache—Doxorubicin—uterine cancer	1.46e-05	0.000496	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.43e-05	0.000736	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKR1C3—uterine cancer	1.4e-05	0.000725	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—uterine cancer	1.38e-05	0.00047	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR1—uterine cancer	1.37e-05	0.000709	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.33e-05	0.000686	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PGR—uterine cancer	1.24e-05	0.00064	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—uterine cancer	1.24e-05	0.000639	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.22e-05	0.00063	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—POLD1—uterine cancer	1.22e-05	0.00063	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.2e-05	0.000622	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.18e-05	0.00061	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—EZH2—uterine cancer	1.18e-05	0.000607	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—STK11—uterine cancer	1.14e-05	0.00059	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP19A1—uterine cancer	1.14e-05	0.00059	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKR1C1—uterine cancer	1.14e-05	0.000589	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP19A1—uterine cancer	1.09e-05	0.000565	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—STK11—uterine cancer	1.09e-05	0.000565	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR2—uterine cancer	1.09e-05	0.000563	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.03e-05	0.00053	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—RRM2—uterine cancer	1.02e-05	0.000525	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.97e-06	0.000515	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—DCN—uterine cancer	9.87e-06	0.00051	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.79e-06	0.000505	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP11A1—uterine cancer	9.3e-06	0.00048	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CDKN2B—uterine cancer	8.88e-06	0.000458	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKR1C3—uterine cancer	8.78e-06	0.000453	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MTHFR—uterine cancer	8.58e-06	0.000443	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MTHFR—uterine cancer	8.22e-06	0.000424	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SMAD3—uterine cancer	8.1e-06	0.000418	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.24e-06	0.000374	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—STK11—uterine cancer	6.84e-06	0.000353	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP19A1—uterine cancer	6.84e-06	0.000353	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR1—uterine cancer	6.61e-06	0.000341	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MTHFR—uterine cancer	5.14e-06	0.000265	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—uterine cancer	4.77e-06	0.000246	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—uterine cancer	4.57e-06	0.000236	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—EP300—uterine cancer	4.55e-06	0.000235	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—EP300—uterine cancer	4.36e-06	0.000225	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—uterine cancer	3.37e-06	0.000174	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—uterine cancer	3.22e-06	0.000167	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—uterine cancer	2.86e-06	0.000148	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—uterine cancer	2.75e-06	0.000142	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—EP300—uterine cancer	2.73e-06	0.000141	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—uterine cancer	2.63e-06	0.000136	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—uterine cancer	2.39e-06	0.000123	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—uterine cancer	2.02e-06	0.000104	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—uterine cancer	1.65e-06	8.51e-05	CbGpPWpGaD
